Literature DB >> 18214057

DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study.

Gabriella Nesi1, Lorenzo Bruno, Calogero Saieva, Anna Caldini, Lucia Roberta Girardi, Ines Zanna, Stefano Rapi, Paolo Bechi, Camillo Cortesini, Domenico Palli.   

Abstract

BACKGROUND: DNA ploidy and S-phase fraction (SPF) measured by DNA flow cytometry (FC) have been previously shown to correlate with several clinicopathological variables in several types of tumours. PATIENTS AND METHODS: DNA FC was performed on multiple frozen tumour samples obtained from 115 patients undergoing curative surgery for gastric cancer (GC). The findings were prospectively tested for correlation with traditional clinicopathological indicators of prognosis.
RESULTS: Overall, 20 tumours (17.4%) were diploid, 46 (40.0%) monoclonal and 49 (42.6%) multiclonal. Excluding 4 patients who died within 1 month of surgery, high SPF (>9.6%) was detected in 55 patients (49.6%) and was found to be significantly associated with vascular invasion and multiclonality (p=0.02). An association of borderline statistical significance emerged with macroscopic type (p=0.06) and pN and pM status (p=0.07). Multivariate regression analysis did not show a significant effect of SPF (p=0.11) or DNA ploidy (p=0.28) on 7-year survival.
CONCLUSION: Aneuploidy appears to be a prognostic factor of low penetrance, whereas SPF is a more promising parameter of tumour aggressiveness in patients with GC.

Entities:  

Mesh:

Year:  2007        PMID: 18214057

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

2.  The prognostic value of β-catenin and LEF-1 expression in patients with operable gastric carcinoma.

Authors:  Serap Kaya; Mahmut Gumus; Yesim Gurbuz; Devrim Cabuk; Ozgur Acikgoz; Suleyman Temiz; Kazim Uygun
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 3.  Genomic and genetic alterations influence the progression of gastric cancer.

Authors:  Stefania Nobili; Lorenzo Bruno; Ida Landini; Cristina Napoli; Paolo Bechi; Francesco Tonelli; Carlos A Rubio; Enrico Mini; Gabriella Nesi
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

4.  Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival.

Authors:  J A M Belien; T E Buffart; A J Gill; M A M Broeckaert; P Quirke; G A Meijer; H I Grabsch
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.